19th DIA Japan Annual Meeting 2022

New “Quest for the future”~Moving Creativity and Innovation Forward in “New Normal”~

LS29 Has RMP Changed Post-Marketing Safety Management in Japan in the 10 Years Since it Started?

Session Chair(s)

Mamoru Narukawa, PhD, RPh

• Professor, Department of Clinical Medicine (Pharmaceutical Medicine)
• Graduate School of Pharmaceutical Sciences, Kitasato University, Japan

Speaker(s)

Shinya Takemoto, MSc

• Group Manager, Safety Information Strategy Group, Risk Communication Department
• Chugai Pharmaceutical Co., Ltd., Japan

Masahiro Hayashi, PhD

• Pharmaceutical affairs specialist, Department of Pharmacy
• Toranomon Hospital, Japan

Eiji Saito

• Reviewer
• Pharmaceuticals and Medical Devices Agency (PMDA), Japan